TM6SF2 and hepatocellular carcinoma: On the other hand, Newberry et al. demonstrated that liver-specific deletion of Tm6sf2 promoted steatosis, fibrosis, and hepatocellular cancer in mice by impairing the very low-density lipoprotein secretion (Newberry et al., 2021).